COVID-19 quarantine measures are associated with negative social impacts and compromised follow-up care in patients with inflammatory bowel disease in Brazil

被引:12
作者
Feitosa, Marley Ribeiro [1 ]
Parra, Rogerio Serafim [1 ]
de Camargo, Hugo Parra [1 ]
Ferreira, Sandro Costa [2 ]
de Almeida Troncon, Luiz Ernesto [2 ]
Ribeiro da Rocha, Jose Joaquim [1 ]
Feres, Omar [1 ]
机构
[1] Univ Sao Paulo, Ribeirao Preto Med Sch, Dept Surg & Anat, Ribeirao Preto, SP, Brazil
[2] Univ Sao Paulo, Ribeirao Preto Med Sch, Dept Clin Med, Ribeirao Preto, SP, Brazil
来源
ANNALS OF GASTROENTEROLOGY | 2021年 / 34卷 / 01期
关键词
Inflammatory bowel disease; Crohn's disease; ulcerative colitis; outcome assessment; healthcare; ANTI-TNF DISCONTINUATION; IBD;
D O I
10.20524/aog.2020.0558
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background COVID-19 has affected the entire world. We aimed to determine the impact of COVID-19 containment measures on the daily life and follow up of patients with inflammatory bowel disease (IBD). Methods During May 2020, we evaluated 179 (79.6%) patients with Crohn's disease (CD) and 46 (20.4%) with ulcerative colitis (UC) by telephone, using a structured questionnaire to gather information on social impact and IBD follow up. Results Some kind of social distancing measure was reported by 95.6% of our patients, self-quarantine (64.9%) being the most frequent. Depressive mood was the most prevalent social impact ( 80.2%), followed by anxiety/fear of death (58.2%), insomnia (51.4%), daily activity impairment (48%), sexual dysfunction (46.2%), and productivity impairment (44%). The results were similar when we compared patients with active disease to those in remission and patients with UC to those with CD. Analysis of IBD follow up showed that 83.1% of all patients missed an IBD medical appointment, 45.5% of the patients missed laboratory tests, 41.3% missed the national flu vaccination program, 31.3% missed any radiologic exam, 17.3% missed colonoscopy, and 16.9% failed to obtain biologic therapy prescriptions. Biologics were discontinued by 28.4% of the patients. UC patients had higher rates of missed vaccination than CD patients ( 56.5% vs. 37.4%, P=0.02) and more failures to obtain a biologic prescription (28.3% vs. 14.0%, P=0.02). Conclusions Our study reveals alarming social impacts and declining follow-up care for IBD patients during the COVID-19 outbreak. These findings may have implications for disease control in the near future.
引用
收藏
页码:39 / 45
页数:7
相关论文
共 49 条
[11]   Emerging coronaviruses: Genome structure, replication, and pathogenesis [J].
Chen, Yu ;
Liu, Qianyun ;
Guo, Deyin .
JOURNAL OF MEDICAL VIROLOGY, 2020, 92 (04) :418-423
[12]   Systematic review with meta-analysis: comparative efficacy of biologics for induction and maintenance of mucosal healing in Crohn's disease and ulcerative colitis controlled trials [J].
Cholapranee, A. ;
Hazlewood, G. S. ;
Kaplan, G. G. ;
Peyrin-Biroulet, L. ;
Ananthakrishnan, A. N. .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2017, 45 (10) :1291-1302
[13]   Impact assessment of non-pharmaceutical interventions against coronavirus disease 2019 and influenza in Hong Kong: an observational study [J].
Cowling, Benjamin J. ;
Ali, Sheikh Taslim ;
Ng, Tiffany W. Y. ;
Tsang, Tim K. ;
Li, Julian C. M. ;
Fong, Min Whui ;
Liao, Qiuyan ;
Kwan, Mike Y. W. ;
Lee, So Lun ;
Chiu, Susan S. ;
Wu, Joseph T. ;
Wu, Peng ;
Leung, Gabriel M. .
LANCET PUBLIC HEALTH, 2020, 5 (05) :E279-E288
[14]  
D'Amico Ferdinando, 2020, Gastroenterology, V158, P2302, DOI 10.1053/j.gastro.2020.04.032
[15]   Management of IBD during the COVID-19 outbreak: resetting clinical priorities [J].
Danese, Silvio ;
Cecconi, Maurizio ;
Spinelli, Antonino .
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY, 2020, 17 (05) :253-255
[16]   Telemonitoring of Crohn's Disease and Ulcerative Colitis (TECCU): Cost-Effectiveness Analysis [J].
Del Hoyo, Javier ;
Nos, Pilar ;
Bastida, Guillermo ;
Faubel, Raquel ;
Munoz, Diana ;
Garrido-Marin, Alejandro ;
Valero-Perez, Elena ;
Bejar-Serrano, Sergio ;
Aguas, Mariam .
JOURNAL OF MEDICAL INTERNET RESEARCH, 2019, 21 (09)
[17]   Inflammatory Bowel Disease Care in the COVID-19 Pandemic Era: The Humanitas, Milan, Experience [J].
Fiorino, Gionata ;
Allocca, Mariangela ;
Furfaro, Federica ;
Gilardi, Daniela ;
Zilli, Alessandra ;
Radice, Simona ;
Spinelli, Antonino ;
Danese, Silvio .
JOURNAL OF CROHNS & COLITIS, 2020, 14 (09) :1330-1333
[18]   Management of inflammatory bowel disease patients in the COVID-19 pandemic era: a Brazilian tertiary referral center guidance [J].
Freitas Queiroz, Natalia Sousa ;
Barros, Luisa Leite ;
Cardoso de Azevedo, Matheus Freitas ;
Oba, Jane ;
Sobrado, Carlos Walter ;
Carlos, Alexandre de Sousa ;
Milani, Luciane Reis ;
Sipahi, Aytan Miranda ;
Mourao Cintra Damiao, Aderson Omar .
CLINICS, 2020, 75
[19]  
Garcia LP, 2020, EPIDEMIOL SERV SAUDE, V29, DOI [10.5123/S1679-49742020000200009, 10.5123/s1679-49742020000200009]
[20]   The Risk of Relapse after Anti-TNF Discontinuation in Inflammatory Bowel Disease: Systematic Review and Meta-Analysis [J].
Gisbert, Javier P. ;
Marin, Alicia C. ;
Chaparro, Maria .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2016, 111 (05) :632-647